Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: Findings from the Fabry Registry

The metabolic and molecular bases of inherited disease

Ying-Tsong Chen · Medical Entomology and Zoology · 2001 · 6.9K citations

Life Sciences, Genetics, Molecular Genetics +14

Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease

Christine M. Eng, Nathalie Guffon, William R. Wilcox et al. · New England Journal of Medicine · 2001 · 1.5K citations · Full text

Medicine, Clinical Sciences, Pharmacology +14

The Importance of Placebo Effects in Pain Treatment and Research

Judith A. Turner · JAMA · 1994 · 863 citations

Medicine, Pharmacotherapy, Surgery +17

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

Atul Mehta, Renato Pietro Ricci, Urs Widmer et al. · European Journal of Clinical Investigation · 2004 · 852 citations · Full text

Life Sciences, Biochemistry, Clinical Sciences +12

Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities

Felix Angst, Andr� Aeschlimann, Gerold Stucki · Arthritis & Rheumatism · 2001 · 774 citations

Medicine, Orthopaedic Surgery, Rehabilitation Medicine +17